Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2009
04/21/2009CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents
04/21/2009CA2356263C Aminopyrazole derivatives
04/16/2009WO2009047514A1 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use
04/16/2009WO2009047359A1 Inhibitors of protein kinases
04/16/2009WO2009047161A1 Chiral cis-imidazolines
04/16/2009WO2009046804A1 Imidazole derivatives
04/16/2009WO2009046802A1 N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators
04/16/2009WO2009006066A3 Process for the preparation of benzimidazol thienylamine compounds and intermediates thereof
04/16/2009WO2008108380A3 Pyrrole compounds
04/16/2009WO2008103277A3 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
04/16/2009US20090099249 Therapeutic lactams
04/16/2009US20090099207 Cyclic sulfones useful as BACE inhibitors
04/16/2009US20090099205 Chemokine receptor binding compounds
04/16/2009US20090099160 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors
04/16/2009US20090099155 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
04/16/2009US20090099143 Tetrahydro-indazole cannabinoid modulators
04/16/2009CA2702265A1 Novel seh inhibitors and their use
04/16/2009CA2702008A1 Inhibitors of protein kinases
04/16/2009CA2701932A1 Chiral cis-imidazolines
04/16/2009CA2701839A1 N- (pyrazole-3-yl) -benzamide derivatives as glucokinase activators
04/16/2009CA2701568A1 Imidazole derivatives
04/15/2009EP2048145A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
04/15/2009EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
04/15/2009EP2046785A1 1,4-bis(2-thienylvinyl)benzol derivatives and their use
04/15/2009EP2046784A2 Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same
04/15/2009EP2046774A1 Pyrazole derivatives as cytochrome p450 inhibitors
04/15/2009EP2046714A2 Therapeutic compounds
04/15/2009EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
04/15/2009EP1689720B1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
04/15/2009EP1572686B1 Anthranilic acid amide derivatives and their pharmaceutical use
04/15/2009CN101410392A Amide substituted quinolines
04/15/2009CN101410387A Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
04/15/2009CN101407495A Preparations and uses of isoquinolinium compounds and salts thereof
04/15/2009CN101407494A Preparations and uses of isoquinolinium compounds and salts thereof
04/15/2009CN101407493A Organic material and use thereof in organic EL device
04/15/2009CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
04/14/2009US7517998 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
04/14/2009US7517994 Heterocyclic inhibitors of MEK and methods of use thereof
04/14/2009US7517992 (-)-cis-1-(5-(4-fluorophenoxy)-pyridin-2-yl)-3-(4,7-difluoro-1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea; improved resistance and pharmacokinetic profile; polymerase inhibitors; potent against virus comprising drug escape mutations
04/14/2009US7517989 Piperidine derivatives useful as modulators of chemokine receptor activity
04/14/2009US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase
04/14/2009US7517902 1-[4-(3-amino-7-fluoro-1H-indazol-6-yl)phenyl]-3-(2-fluoro-5-trifluoromethyl-phenyl)urea; protein kinases (Vascular Endothelial Growth Factor Receptor 2 and Tie-2), inhibitor; anticarcinogenic, antiinflammatory agent; neovascularization, lung and breast cancer, rheumatoid arthritis
04/14/2009US7517900 Pyrazole derivatives as cannabinoid receptor modulators
04/14/2009US7517894 Endothelial growth factor; angiogenesis inhibitor; antitumor agents; skin disorders; endometriosis; Crohn's disease; leukemia; antiarthritic agents
04/14/2009US7517879 Pyrrolidine derivatives as factor Xa inhibitors
04/14/2009US7517878 For example, 2-([3-tert-butyl-1-(2-methylphenyl)-1H-pyrazol-5-yl]amino)-6-methylnicotinic acid; compounds stimulate insulin secretion in the presence of glucose
04/14/2009US7517877 5-substituted-alkylaminopyrazole derivatives as pesticides
04/14/2009US7517875 Piperidine derivatives having CCR3 antagonism
04/14/2009US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
04/14/2009CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
04/14/2009CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
04/14/2009CA2371789C Novel guanidine derivatives as inhibitors of cell adhesion
04/14/2009CA2256007C Substituted heterocyclic benzocycloalkenes and their use as analgesic
04/14/2009CA2170479C Benzothiophene compounds, intermediates, compositions, and methods
04/09/2009WO2009046416A1 Anilinopyrimidines as jak kinase inhibitors
04/09/2009WO2009044311A1 Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor
04/09/2009WO2009044162A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
04/09/2009WO2009043780A1 Tetrazole-substituted aryl amide derivatives and uses thereof
04/09/2009WO2009021868A3 Novel piperazine amide derivatives
04/09/2009WO2009016218A3 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
04/09/2009WO2008155666A3 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
04/09/2009WO2008121592A3 Acetyl coenzyme a carboxylase inhibitors
04/09/2009WO2008074997A8 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors
04/09/2009WO2006050120A3 Synthesis of cox-2 and faah inhibitors
04/09/2009US20090093521 2, 5-Bis-Diamine [1,4] Benzoquinone-Derivatives
04/09/2009US20090093494 4-Pyrimidineamine Compounds And Uses As Anti-Proliferative Agents
04/09/2009US20090093479 Anti-cancer agents and uses thereof
04/09/2009US20090093478 N-aroyl cyclic amines
04/09/2009US20090093469 Phenylaminopropanol Derivatives and Methods of Their Use
04/09/2009US20090093452 Pyrrole, Thiophene, Furan, Imidazole, Oxazole, and Thiazole Derivatives
04/09/2009DE4448032B4 Zusammensetzung enthaltend organische Materialien und 3-Aryl-benzofuranone als Stabilisatoren A composition comprising organic materials and 3-aryl-benzofuranones as stabilizers
04/09/2009CA2738980A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use
04/09/2009CA2701768A1 Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor
04/09/2009CA2701214A1 Tetrazole-substituted aryl amide derivatives and uses thereof
04/09/2009CA2701124A1 C-met protein kinase inhibitors
04/08/2009EP2045245A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof
04/08/2009EP2044061A2 Benzothiophene inhibitors of rho kinase
04/08/2009EP2044060A1 Fungicide hydroximoyl-tetrazole derivatives
04/08/2009EP2044050A1 New pyridine analogues
04/08/2009EP2044024A1 New pyridine analogues
04/08/2009EP2044017A2 Substituted phenyl acetic acids as dp-2 antagonists
04/08/2009EP2044016A2 4-heteroaryl-substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having effects on the opiod receptor system
04/08/2009EP2043993A2 Cyclopentane derivatives as antiglaucoma agents
04/08/2009EP1670470B1 Pyridine derivatives and use thereof as urotensin ii antagonists
04/08/2009EP1448566B3 Chemokine receptor antagonists and methods of use thereof
04/08/2009EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity
04/08/2009CN101405889A Organic electroluminescence element material and organic electroluminescence element using such material
04/08/2009CN101405347A Organic compound, semiconductor thin film electrode using the same, photoelectric transducer, and photoelectrochemical solar cell
04/08/2009CN101405283A HIV inhibiting 5-amido substituted pyrimidines
04/08/2009CN101405282A Aurora kinase modulators and method of use
04/08/2009CN101405275A Triazolone derivative
04/08/2009CN101402632A Aryl hydrazide compounds with antineoplastic activity
04/08/2009CN101402623A 3-substituted benzene phthalein compounds with biological activity
04/08/2009CN101402554A 2- and 2,5-substituted phenylketo-enols
04/08/2009CN100475793C Quinazoline derivatives and use for preparing medicine
04/08/2009CN100475792C Novel gamma-secretase inhibitors
04/08/2009CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2009CN100475777C Amide type carboxamide derivative
04/08/2009CN100475040C Aminocarbonyl-substituted thiensulphonylamino (thio) carbonyltriazolin (thi) ones, methods for production and use thereof
04/07/2009US7514570 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer